Target Information

Evonik has finalized the sale of its superabsorbents business unit to the International Chemical Investors Group (ICIG), with the transaction closing on August 31, 2024, following regulatory approval. This specialized division, which focuses on powdered polymers, plays a crucial role in the manufacturing of absorbent materials for hygiene products, such as diapers. In 2023, the superabsorbents unit generated sales of €892 million and employed approximately 1,000 staff across three facilities in Germany and two in the United States.

This divestment marks the second phase of Evonik's broader strategy to streamline its Performance Materials division, having already sold the Lülsdorf site and its related businesses to ICIG. The remaining segment of the division includes the former Performance Intermediates business line, for which Evonik is exploring market opportunities for a potential sale.

Industry Overview in Germany

Germany is one of the leading players in the global chemical industry, characterized by its innovative capabilities and strong regulatory frameworks. The country has a robust infrastructure for chemical manufacturing and a skilled workforce, supporting the production of diverse chemical products, including polymers used in various applications. The sector benefits from significant investments in research and development, aligned with Germany's commitment to sustainability and environmental responsibility.

The superabsorbents market has seen stable growth, driven by increasing demand for hygiene products across various demographics, particularly due to rising awareness around hygiene and sanitation. Germany's chemical industry is positioned to capitalize on this trend, owing to its advanced technological capabilities and a strong base of established companies focused on sustainable practices.

In recent years, the German government has emphasized the importance of digitalization and innovation within the chemical sector, enhancing competitiveness while addressing environmental challenges. This focus is evident through funding initiatives aimed at facilitating the transition towards more sustainable production methods that reduce carbon footprints.

Moreover, the demand for superabsorbents is anticipated to expand further, spurred by global market trends such as the growing population and the increasing affordability of hygiene products. Given these factors, companies within the sector are likely to experience favorable market conditions for continued growth and investment.

Rationale Behind the Deal

The sale of the superabsorbents business unit aligns with Evonik's strategic goal of concentrating on high-margin operations that contribute to the green transformation of the economy. Christian Kullmann, Chairman of the Executive Board, underscored the company’s intent to prioritize stability-seeking enterprises and maintain responsible practices throughout the transition for their employees.

Conversely, this acquisition provides ICIG with the opportunity to enhance its portfolio and expand its footprint in the high-demand polymer market, positioning the company for sustained growth in a critical industry segment.

Information About the Investor

International Chemical Investors Group (ICIG) is a well-established chemical investment firm headquartered in Frankfurt am Main. With a strategic focus on growth-oriented opportunities, ICIG generates annual sales exceeding €4 billion and operates from around 50 locations worldwide, employing over 7,800 staff. The group's acquisition strategy utilizes both internal and external growth methods to diversify and strengthen its portfolio.

ICIG's leadership, represented by Dr. Achim Riemann, expresses confidence in integrating the superabsorbents unit, considering it an essential platform for future expansion. The group has demonstrated a proactive approach toward embracing opportunities that enhance its competitive edge in the evolving chemical landscape.

View of Dealert

This acquisition of Evonik’s superabsorbents business unit by ICIG can be seen as a strategic and potentially fruitful investment. The stable growth trajectory of the superabsorbents market coupled with ICIG's operational capacity suggests that the new addition will significantly bolster the group's market presence and revenue streams.

Furthermore, the increasing demand for sustainable and innovative hygiene solutions is likely to enhance the unit's profitability under ICIG's management. Integrating these operations into their existing framework may lead to synergies that enhance efficiency and reduce operational costs.

However, it's essential to consider the competitive dynamics within the chemical industry. While the prospects appear favorable, ICIG must navigate potential challenges related to integration, market fluctuations, and operational scalability to fully realize the investment's potential.

In conclusion, assuming careful execution of their growth strategies and a supportive market environment, this deal could represent a valuable addition to ICIG’s portfolio and a sound investment in the expanding sector of superabsorbents.

View Original Article

International Chemical Investors Group (ICIG)

invested in

Evonik's superabsorbents business unit

in 2024

in a Buyout deal

Disclosed details

Revenue: $892M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert